Lanthanides

SeraCare Life Sciences Launches First-Ever Tumor Mutational Burden Reference Materials

Retrieved on: 
Thursday, October 31, 2019
Physical sciences, Chemistry, Natural sciences, Lanthanides, Metals, Thulium, Assay, TMB

SeraCare was selected to provide FFPE TMB reference materials as part of IQN-Path's TMB EQA Pilot Program, and to 16 participating laboratories in the Phase II project of Friends' TMB Harmonization Working Group.

Key Points: 
  • SeraCare was selected to provide FFPE TMB reference materials as part of IQN-Path's TMB EQA Pilot Program, and to 16 participating laboratories in the Phase II project of Friends' TMB Harmonization Working Group.
  • The results demonstrate the utility of these TMB reference materials in harmonizing and standardizing measurements of TMB by different NGS assays.
  • In addition to the Seraseq TMB gDNA and FFPE reference materials available now, SeraCare can create custom tissue and blood-based TMB reference materials through their VariantFlexTM custom reference material development platform.
  • LGC is an international life sciences measurement and testing company with leading positions in growing markets.

Cook Medical and Quanta System Announce Distribution Agreement for Laser Systems

Retrieved on: 
Wednesday, October 30, 2019
Surgery, Medical devices, Medical Supplies, Hospitals, Biotechnology, Other Health, Radiology, Health, General Health, Physical sciences, Chemistry, Chemical substances, Chemical elements, Lanthanides, Reducing agents, Quantum optics, Laser, Photonics, Quanta, Thulium, Holmium(III) oxide, Surgery, Medical devices, Medical Supplies, Hospitals, Biotechnology, Other Health, Radiology, Health, General Health, Physical sciences, Chemistry, Chemical substances, Chemical elements, Lanthanides, Reducing agents, Quantum optics, Laser, Photonics, Quanta, Thulium, Holmium(III) oxide, Cook Medical, Quanta

Cook Medical and Quanta System have entered into an agreement in which Cook will distribute a comprehensive offering of Quantas holmium and thulium laser systems, laser fibers and accessories.

Key Points: 
  • Cook Medical and Quanta System have entered into an agreement in which Cook will distribute a comprehensive offering of Quantas holmium and thulium laser systems, laser fibers and accessories.
  • Quanta is a progressive laser manufacturer with an expanding global presence, and we are eager to bring Quantas robust line of laser systems and fibers to Cooks customers.
  • The Quanta laser systems will be available in the United States beginning in late 2019 and in other countries in 2020.
  • Quanta System is a 100% Italian company that has offered on the global market innovative laser systems for surgery, aesthetics and art conservation since 1985.

Global Neodymium Market Forecasts: Coverage Through 2019-2024 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 15, 2019
Chemicals, Plastics, Manufacturing, Chemistry, Physical sciences, Natural sciences, Chemical elements, Reducing agents, Lanthanides, Neodymium, Praseodymium, Rare-earth element, Boron, Yttrium, Dysprosium

The "Global Neodymium Market - Forecasts from 2019 to 2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Neodymium Market - Forecasts from 2019 to 2024" report has been added to ResearchAndMarkets.com's offering.
  • The global neodymium market was valued at US$1.521 billion in 2018 and is estimated to grow at a good CAGR during the forecast period 2018-2024.
  • Neodymium (Nd) is a soft and silvery chemical element having 60 as atomic number and 144.242u as atomic weight.
  • Geographically, Asia Pacific holds a significant share in the market on account of China holding a major share in the global production of rare earth elements.

SHINE closes $50-million financing with Oaktree to support execution of construction and commercialization plans

Retrieved on: 
Monday, October 7, 2019
Medical devices, Cardiology, Radiology, Pharmaceutical, Health, General Health, Oncology, Physical sciences, Chemistry, Natural sciences, Chemical elements, Medicinal radiochemistry, Lanthanides, Lutetium, Nuclear medicine, Molybdenum, Shine, Medical Isotopes, SHINE Medical Technologies LLC

The financing supports the ongoing construction of SHINEs medical isotope production facility and its commercialization of diagnostic and therapeutic isotopes, including molybdenum-99 (Mo-99) and lutetium-177 (Lu-177).

Key Points: 
  • The financing supports the ongoing construction of SHINEs medical isotope production facility and its commercialization of diagnostic and therapeutic isotopes, including molybdenum-99 (Mo-99) and lutetium-177 (Lu-177).
  • We are excited to welcome Oaktree to SHINEs growing list of top-tier institutional investors, said Greg Piefer, founder and CEO of SHINE.
  • Construction of SHINEs production facility is expected to be completed in 2021 and commercial-scale isotope production should begin in 2022.
  • Oaktree is confident SHINE will play a major role in ending that shortage and we are pleased to support SHINEs production facility construction.

Promethium First to Combine Natural Language Processing with Analytics

Retrieved on: 
Monday, October 7, 2019
Articles, Physical sciences, Formal sciences, Business intelligence, Academic disciplines, Lanthanides, Promethium, Analytics, Natural language processing

MENLO PARK, Calif., Oct. 7, 2019 /PRNewswire/ -- AI-driven augmented data management provider Promethium today announced the release of its new AI-powered Data Navigation System (DNS), the first analytics solution to use natural language processing (NLP) to generate complex SQL queries from human language requests.

Key Points: 
  • MENLO PARK, Calif., Oct. 7, 2019 /PRNewswire/ -- AI-driven augmented data management provider Promethium today announced the release of its new AI-powered Data Navigation System (DNS), the first analytics solution to use natural language processing (NLP) to generate complex SQL queries from human language requests.
  • With Promethium, business analysts and other non-technical professionals can use plain language to tap their organization's data for answers to complex questions.
  • "Our Data Navigation System provides a fully automated solution that helps enterprises extract answers across the most diverse and complex sources, with nothing more than natural language," said Kaycee Lai, CEO and Founder of Promethium.
  • Promethium is an augmented data management provider and the first company to combine natural language processing with self-service analytics, which allows users to tap their organization's entire data estate for answers to questions asked in plainspoken language.

ITM and Bruce Power Successfully Complete Feasibility Study

Retrieved on: 
Monday, September 30, 2019
Medical devices, Clinical trials, Biotechnology, Radiology, Pharmaceutical, Health, Oncology, Physical sciences, Natural sciences, Chemistry, Radioactivity, Chemical elements, Lanthanides, Radiobiology, Areva, Framatome, Lutetium, Ytterbium, Bruce Power

ITM Isotopen Technologien Mnchen AG (ITM), a biotechnology and radiopharmaceutical group of companies, and Bruce Power, a Canadian-based nuclear generator and isotope supplier, announced today that they have successfully completed a joint feasibility study at Bruce Powers Nuclear Facilities for the irradiation of Ytterbium-176.

Key Points: 
  • ITM Isotopen Technologien Mnchen AG (ITM), a biotechnology and radiopharmaceutical group of companies, and Bruce Power, a Canadian-based nuclear generator and isotope supplier, announced today that they have successfully completed a joint feasibility study at Bruce Powers Nuclear Facilities for the irradiation of Ytterbium-176.
  • The intermediate material to be generated at Bruce Power will be processed to the high purity medical radioisotope n.c.a.
  • ITM and Bruce Power have come to the conclusion that Bruce Power and its partners Framatome and Kinectrics, following regulatory and other approvals, are uniquely positioned to fulfil the necessary requirements to establish isotope production units at the Bruce Power Reactors that meet the high standards required for ITMs proprietary n.c.a Lutetium-177 production process.
  • After the excellent results of our joint feasibility study with Bruce Power and its partners Framatome and Kinectrics we are looking forward to the start of the construction of the irradiation facilities at Bruce Power shortly added Steffen Schuster, CEO of ITM.

Samarium Cobalt Magnet Demand to Expand 6.3% Annually Through 2023 - Freedonia Group Analysis

Retrieved on: 
Friday, September 27, 2019
Physical sciences, Electromagnetism, Chemistry, Ferromagnetic materials, Chemical elements, Magnetic alloys, Lanthanides, Reducing agents, Rare-earth magnet, Samarium–cobalt magnet, Neodymium, Rare-earth element

These and other trends are presented in the study Global Magnets from The Freedonia Group.

Key Points: 
  • These and other trends are presented in the study Global Magnets from The Freedonia Group.
  • Samarium cobalt magnets which are also called rare earth cobalt, RECo magnets are composed of the rare earth element samarium and cobalt, and typically also contain iron, copper, and zirconium.
  • Along with neodymium magnets, samarium cobalt magnets are often referred to as rare earth magnets.
  • About The Freedonia Group The Freedonia Group, a division of MarketResearch.com, is a leading international industrial research company publishing more than 100 studies annually.

WONTECH's Holmium laser 'Holinwon Prima' Received FDA approval

Retrieved on: 
Friday, September 6, 2019
Physical sciences, Chemistry, Chemical elements, Lanthanides, Reducing agents, Laser medicine, Holmium, Laser surgery, Laser, Food and Drug Administration, Erbium, Medical device

SEOUL, South Korea, Sept. 6, 2019 /PRNewswire/ -- WONTECH, a leading Korean medical device company, announced that its Holmium laser device, Holinwon Prima, received U.S. Food and Drug Administration approval.

Key Points: 
  • SEOUL, South Korea, Sept. 6, 2019 /PRNewswire/ -- WONTECH, a leading Korean medical device company, announced that its Holmium laser device, Holinwon Prima, received U.S. Food and Drug Administration approval.
  • Holinwon Prima, approved by the FDA, is the first Holmium laser medical device developed in Korea.
  • When tissue is dissected, detailed and sophisticated laser surgery is possible while minimizing damage to surrounding tissues.
  • Seung-woo Song, Chief ofthe U.S branch of WONTECH said, "We were delighted to receive FDA approval for the first time in Korea with the effectiveness and stability of WONTECH's holmium laser device.

ITM and DCB Sign Exclusive Licensing & Development Agreement for Solucin® TRT in South Korea while COMPETE Clinical Trial Sees Strong Growth in Recruitment Numbers in the U.S.

Retrieved on: 
Monday, September 2, 2019
Biotechnology, Pharmaceutical, Oncology, Health, Genetics, Clinical trials, Health, Drug discovery, Articles, Lanthanides, Lutetium, Clinical trial, Therapy

The agreement sets out terms concerning the local development, registration and subsequent commercialization by DCB of ITMs proprietary brand Solucin for Targeted Radionuclide Therapy (TRT) in South Korea.

Key Points: 
  • The agreement sets out terms concerning the local development, registration and subsequent commercialization by DCB of ITMs proprietary brand Solucin for Targeted Radionuclide Therapy (TRT) in South Korea.
  • Within the framework of this collaboration, DCB and ITM plan to initiate a local clinical study for ITMs Solucin TRT which is expected to begin recruiting patients in 2020.
  • COMPETE involves 42 leading cancer centers in 12 countries, predominantly in Europe, North America, South Africa and Australia.
  • The COMPETE clinical trial is an international multi-center phase III clinical study evaluating the efficacy and safety of Targeted Radionuclide Therapy with no-carrier-added Lutetium-177-Edotreotide (Solucin).

Researchers Use Nano-Particles to Increase Power, Improve Eye Safety of Fiber Lasers

Retrieved on: 
Wednesday, July 17, 2019
Physical sciences, Chemistry, Chemical elements, Lanthanides, Reducing agents, Photonics, Laser, Holmium, Erbium, Rare-earth element, Optical fiber

Put simply, it's laser light pumping a silica fiber that has been infused with rare earth ions of holmium.

Key Points: 
  • Put simply, it's laser light pumping a silica fiber that has been infused with rare earth ions of holmium.
  • "Doping just means we're putting rare earth ions into the core of the fiber, which is where all the action happens," Sanghera explained.
  • Of course, Baker pointed out, no laser can be said to be safe when it comes to the human eye.
  • The danger arises from the potential of scattered light to be reflected into the eye during a laser's operation.